Abstract:Background: Targeted radiotherapies with low-energy ions show interesting possibilities for the selective irradiation of tumor cells, a strategy particularly appropriate for the treatment of disseminated cancer. Two promising examples are boron neutron capture therapy (BNCT) and targeted radionuclide therapy with alpha-particle emitters (TAT). The successful clinical translation of these radiotherapies requires the implementation of accurate radiation dosimetry approaches able to take into account the impact on treatments of the biological effectiveness of ions and the heterogeneity in the therapeutic agent distribution inside the tumor cells. To this end, biophysical models can be applied to translate the interactions of radiations with matter into biological endpoints, such as cell survival. Purpose: The NanOx model was initially developed for predicting the cell survival fractions resulting from irradiations with the high-energy ion beams encountered in hadrontherapy. We present in this work a new implementation of the model that extends its application to irradiations with low-energy ions, as the ones found in TAT and BNCT. Methods: The NanOx model was adapted to consider the energy loss of primary ions within the sensitive volume (i.e., the cell nucleus). Additional assumptions were introduced to simplify the practical implementation of the model and reduce computation time. In particular, for low-energy ions the narrow-track approximation allowed to neglect the energy deposited by secondary electrons outside the sensitive volume, increasing significantly the performance of simulations. Calculations were performed to compare the original hadrontherapy implementation of the NanOx model with the present one in terms of the inactivation cross sections of human salivary gland cells as a function of the kinetic energy of incident alpha-particles. Results: The predictions of the previous and current versions of NanOx agreed for incident energies higher than 1 MeV/n. For lower energies, the new NanOx implementation predicted a decrease in the inactivation cross sections that depended on the length of the sensitive volume. Conclusions: We reported in this work an extension of the NanOx biophysical model to consider irradiations with low-energy ions, such as the ones found in TAT and BNCT. The excellent agreement observed at intermediate and high energies between the original hadrontherapy implementation and the present one showed that NanOx offers a consistent, self-integrated framework for describing the biological effects induced by ion irradiations. Future work will focus on the application of the latest version of NanOx to cases closer to the clinical setting.

The effects of nuclear level density model and alpha optical model potential to the excitation functions of novel therapeutic radionuclides

The Combination Effect of Optical Potential and Nuclear Level Density for Alpha Induced Reaction Cross Sections on 92,94,95 Mo Isotopes

Statistical analysis of proton induced reactions to generate recommended data for the production of medical radio-isotopes

An attempt to explore the production routes of Astatine radionuclides: Theoretical approach

Systematic study of theoretical estimation of nuclear reaction cross section of proton-induced reactions on Neodymium target upto 65 MeV using TALYS-1.96 code

Impact of nuclear level density and radiative strength function models on the S factors of (α,γ) reactions relevant to p-nuclei production

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice

A photon source model for alpha-emitter radionuclides

Primary study of the relative and compound biological effectiveness model for boron neutron capture therapy based on nanodosimetry

Dosimetry at cellular level for the alpha-emitting radionuclides actinium-225, astatine-211 and radium-223 for bone metastasis cells from castration resistant prostate cancer

Biophysical modeling of low-energy ion irradiations with NanOx

Investigation of 209Bi (α,2n)211At reaction route for the production of α-emitter 211At

Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA Mainz

An alpha decay study of superheavy nuclei within a Coulomb and proximity potential model including a Q-value dependent surface diffuseness parameter

Dosimetry study on Auger electron-emitting nuclear medicine radioisotopes in micrometer and nanometer scales using Geant4-DNA simulation

Absorbed dose evaluation of Auger electron-emitting radionuclides: impact of input decay spectra on dose point kernels and S-values

In vitro and preclinical systematic dose-effect studies of Auger electron- and beta particle-emitting radionuclides and external beam radiation for cancer treatment

Estimation of global level density parameters using an unscented transform Kalman filter technique

Investigation of the cross sections of natCu(α,x)66,67Ga, 65Zn reactions

Determination of $α$-optical potential for reactions with p-nuclei from the study of ($α$,n) reactions in the astrophysically relevant energy region

Low energy alpha-nucleus optical potential studied via (a,n) cross section measurements on Te isotopes